Published on
July 1, 2024
- 13:02 GMT
DispenSecur™ v1 - A Device to Support Individuals with Opioid Use Disorder
RESEARCH TRIANGLE PARK, NORTH CAROLINA, UNITED STATES, July 1, 2024 /EINPresswire.com/ -- Verinetics, Inc. announced today the listing of its first product, DispenSecur™ v1, as a Class I Medical Device with the US Food and Drug Administration. …
Distribution channels:
Emergency Services, Healthcare & Pharmaceuticals Industry
...
